术中技术表现评分预测先天性心脏病手术结局
单中心回顾性研究纳入2011年1月至2019年12月先天性心脏病手术患者6793例,用术中超声心动图分配术中技术表现评分(IO-TPS:1级无残留、2级轻微残留、3级重大残留)。IO-TPS是主要结局的显著预测因子(2级OR 1.7,3级OR 6.0),3级患者晚期死亡/移植和再干预风险也更高。
要点
- IO-TPS 3级患者主要结局风险显著升高(OR 6.0)。
- IO-TPS 2级患者主要结局风险亦升高(OR 1.7)。
- 3级患者晚期死亡/移植(HR 2.2)和再干预(SHR 2.5)风险更高。
核心结论
- IO-TPS与先天性心脏病手术后的早期和晚期不良结局显著相关,可能作为自我评估和质量改进的重要辅助工具。
研究设计与样本
- 单中心回顾性研究,纳入2011年1月至2019年12月接受先天性心脏病手术的患者6793例,使用术中超声心动图分配IO-TPS(1级无残留、2级轻微残留、3级重大残留)。
主要发现
- 主要结局在6793例符合入选标准的患者中观察到784例(11.5%)。
- 多变量分析中,IO-TPS是主要结局的显著预测因子(2级:OR 1.7,95%CI 1.4-2.0,P<.001;3级:OR 6.0,95%CI 4.0-8.9,P<.001)。
- 在6661例出院无移植存活者中(随访至10.5年),发生185例(2.8%)死亡或移植和1171例(17.6%)再干预。
- 与1级患者相比,3级患者晚期死亡或移植的校正风险更高(HR 2.2,95%CI 1.2-4.2,P=.012),晚期再干预风险也更高(亚分布HR 2.5,95%CI 1.8-3.3,P<.001)。
临床怎么用
- 原文结论指出IO-TPS可能作为自我评估和质量改进的重要辅助工具。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The utility of the intraoperative technical performance score (IO-TPS) in predicting outcomes after congenital cardiac surgery remains unknown. METHODS: Data from patients undergoing surgery for congenital heart disease from January 2011 to December 2019 at a single institution were retrospectively reviewed. Intraoperative echocardiograms were used to assign IO-TPS for each index operation (class 1, no residua; class 2, minor residua; class 3, major residua). The primary outcome was a composite of in-hospital mortality, transplant, unplanned reintervention in the anatomic area of repair, and new permanent pacemaker implantation. Secondary outcomes included postdischarge (late) mortality or transplant and unplanned reintervention. Associations between IO-TPS and outcomes were assessed using logistic (primary) and Cox or competing risk (secondary) models, adjusting for preoperative patient- and procedure-related covariates. RESULTS: The primary outcome was observed in 784 (11.5%) of 6793 patients who met entry criteria. On multivariable analysis, IO-TPS was a significant predictor of the primary outcome (class 2: odds ratio, 1.7 [95% CI, 1.4-2.0; P < .001]; class 3: odds ratio, 6.0 [95% CI, 4.0-8.9; P < .001]). Among 6661 transplant-free survivors of hospital discharge observed for up to 10.5 years, there were 185 (2.8%) deaths or transplants and 1171 (17.6%) reinterventions. Class 3 patients had a greater adjusted risk of late mortality or transplant (hazard ratio, 2.2; 95% CI, 1.2-4.2; P = .012) and late reintervention (subdistribution hazard ratio, 2.5; 95% CI, 1.8-3.3; P < .001) vs class 1 patients. CONCLUSIONS: IO-TPS is significantly associated with adverse early and late outcomes after congenital heart surgery and may serve as an important adjunct for self-assessment and quality improvement.
引用
- Sengupta A, Gauvreau K, Kohlsaat K, et al. Intraoperative Technical Performance Score Predicts Outcomes After Congenital Cardiac Surgery. Ann Thorac Surg. 2022. PMID: 35595087. doi:10.1016/j.athoracsur.2022.04.051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。